Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LP5G
|
||||
| Former ID |
DNC012550
|
||||
| Drug Name |
2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530590] | ||
| Formula |
C16H12N4
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)N
|
||||
| InChI |
1S/C16H12N4/c17-15-14-13(11-8-4-5-9-12(11)18-15)19-16(20-14)10-6-2-1-3-7-10/h1-9H,(H2,17,18)(H,19,20)
|
||||
| InChIKey |
IBRIUJBAFMFSDF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530590] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [530590] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [530590] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Parkinson's disease | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Alcoholism | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.